Titan Medical Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Patent Rights

Patent Rights

6 Months Ended

Jun. 30, 2019

Patent Rights [Abstract]

3.	PATENT RIGHTS


For the six months ended June 30, 2019		Cost				Accumulated Amortization & Impairment Losses				Net Book Value
Balance at December 31, 2018			1,398,713				(226,228	)			1,172,485
Additions during the period			178,956				—				178,956
Amortization in the period			—				(13,466	)			(13,466	)

Balance at June 30, 2019			1,577,669				(239,694	)			1,337,975